Literature DB >> 32617964

Pituitary stalk interruption syndrome broadens the clinical spectrum of the TTC26 ciliopathy.

Odeya David1,2,3, Marina Eskin-Schwartz3,4, Galina Ling2,3,5, Vadim Dolgin4, Eyal Kristal2, Ela Benkowitz6, Lidia Osyntsov7, Libe Gradstein4,8, Ohad S Birk4, Neta Loewenthal1,2,3, Baruch Yerushalmi2,3,5.   

Abstract

Ciliopathies are a heterogeneous group of disorders, related to abnormal ciliary function. Severe biliary ciliopathy, caused by bi-allelic mutations in TTC26, has been recently described in the context of a syndrome of polydactyly and severe neonatal cholestasis, with brain, kidney and heart involvement. Pituitary involvement has not been previously reported for patients with this condition. Pituitary stalk interruption syndrome (PSIS) is a congenital anomaly of the pituitary gland, diagnosed by characteristic MRI findings. We now describe four patients with TTC26 ciliopathy due to a homozygous c.695A>G p.Asn232Ser mutation and delineate PSIS as a novel clinical feature of this disorder, highlighting an important role of TTC26 in pituitary development.
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Caroli disease; TTC26; cholestasis; ciliopathy; hypophysis; pituitary

Mesh:

Substances:

Year:  2020        PMID: 32617964     DOI: 10.1111/cge.13805

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

Review 1.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

2.  Identification of the TTC26 Splice Variant in a Novel Complex Ciliopathy Syndrome with Biliary, Renal, Neurological, and Skeletal Manifestations.

Authors:  Majid Alfadhel; Muhammad Umair; Bader Almuzzaini; Abdulaziz Asiri; Abeer Al Tuwaijri; Khaloud Alhamoudi; Yusra Alyafee; Mohammed Al-Owain
Journal:  Mol Syndromol       Date:  2021-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.